Reported Standalone quarterly numbers for Jubilant Pharmova are:
Net Sales at Rs 66.40 crore in September 2025 down 59.93% from Rs. 165.70 crore in September 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 6.40 crore in September 2025 down 160.95% from Rs. 10.50 crore in September 2024.
EBITDA stands at Rs. 12.60 crore in September 2025 down 66.58% from Rs. 37.70 crore in September 2024.
Jubilant Pharmo shares closed at 1,127.20 on November 06, 2025 (NSE) and has given 27.84% returns over the last 6 months and -10.15% over the last 12 months.
Story continues below Advertisement
| Jubilant Pharmova | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'25 | Jun'25 | Sep'24 | | Net Sales/Income from operations | 66.30 | 59.50 | 165.70 | | Other Operating Income | 0.10 | -- | -- | | Total Income From Operations | 66.40 | 59.50 | 165.70 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | 62.20 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -3.80 | | Power & Fuel | -- | -- | -- | | Employees Cost | 26.60 | 23.20 | 51.40 | | Depreciation | 1.60 | 1.50 | 13.30 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 28.00 | 26.00 | 62.00 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 10.20 | 8.80 | -19.40 | | Other Income | 0.80 | 0.70 | 43.80 | | P/L Before Int., Excpt. Items & Tax | 11.00 | 9.50 | 24.40 | | Interest | 2.50 | 3.00 | 7.80 | | P/L Before Exceptional Items & Tax | 8.50 | 6.50 | 16.60 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 8.50 | 6.50 | 16.60 | | Tax | 56.50 | 2.40 | 6.10 | | P/L After Tax from Ordinary Activities | -48.00 | 4.10 | 10.50 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | 41.60 | 1.70 | -- | | Net Profit/(Loss) For the Period | -6.40 | 5.80 | 10.50 | | Equity Share Capital | 15.90 | 15.90 | 15.90 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.40 | 0.36 | 0.66 | | Diluted EPS | -0.40 | 0.36 | 0.66 | | EPS After Extra Ordinary | | Basic EPS | -0.40 | 0.36 | 0.66 | | Diluted EPS | -0.40 | 0.36 | 0.66 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
